News Releases

Michelle Ng Gong, M.D., M.S., Named Chief of Division of Pulmonary Medicine
Susan Band Horwitz Wins Prestigious Cancer Research Award for Anti-Tumor Drug Discovery
Montefiore and Albert Einstein College of Medicine Secure $5.9 Million NCI Grant to Improve Cancer Care for Minority and Underserved Communities

Facts & Stats

Published Papers
NIH Research Funding
Full-time Faculty
Global Initiatives
Clinical and Research Centers

Expert List for Media

Joe Verghese

Joe Verghese, M.B.,B.S.

Area(s) of expertise: Alzheimer's disease/dementiaGait/mobilityAging

Dr. Verghese is an expert on aging who assesses how diseases and aging affect cognitive ability and mobility in older adults. Among his current projects, he is studying whether brain stimulating activities can… Learn more

Einstein in the News

Here's Why Health Experts Want to Stop Daylight-Saving Time (subscription required)

Andrew Krumerman, M.D., comments on the special importance of healthy sleep habits when daylight-saving time begins. His research found that the transition is linked to an increase in hospital admissions for irregular heartbeat. Dr. Krumerman is professor of medicine at Einstein and a cardiologist at Montefiore Health System.

The Washington Post
In a Historically Old Presidential Field, Candidates Refuse to Release Health Records

Nir Barzilai, M.D., explains how age is a risk factor for many diseases, but notes a mix of other factors, including genetics and lifestyle, can extend the years one remains free of serious disease. Dr. Barzilai is the Ingeborg and Ira Leon Rennert Chair of Aging Research and director of the Institute for Aging Research at Einstein.

More coverage on Dr. Barzilai

Getting Lots of Exercise Tied to Lower Risk of Kidney Disease

Michal Melamed, M.D., comments on a study finding that people who exercise may be less likely than those who are sedentary to develop kidney disease. Dr. Melamed is associate professor of medicine and of epidemiology & population health at Einstein and a nephrologist at Montefiore.

More coverage on Dr. Melamed


When a Drug Becomes a Child’s Last Hope

Einstein scientist Vern Schramm, Ph.D., never imagined that his basic research into enzymes would intersect with a 2-year-old girl dying from an incurable form of blood cancer. He and that girl (Katie Lambertson, now a teenager) and her parents share their stories.

Watch more videos

The Doctor's Tablet Blog